Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu

June 12, 2025
Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3.07% on June 10, capturing the attention of many in the market. With this promising development, many are curious to see how this will impact the future of the company and its stock. For a professional forecast on the movement of BMY shares, experts recommend consulting Stocks Prognosis.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

It's good to see positive trial results, but I wonder about the potential challenges and risks ahead for Bristol-Myers Squibb. I'll be monitoring the situation closely
— from WealthyWendy at 06-14-2025 03:03
This is great news! I'm looking forward to seeing the impact of these positive trial results on Bristol-Myers Squibb's future
— from PennyParker at 06-13-2025 22:17
Les résultats positifs de l'essai de phase 3 pour Sotyktu sont très prometteurs pour Bristol-Myers Squibb. J'ai hâte de voir comment cela influencera l'entreprise
— from GrowthGiselle at 06-12-2025 23:07
I'm not entirely convinced that these trial results will lead to long-term success for Bristol-Myers Squibb. More data and analysis are needed before making any conclusions
— from TylerGonzalez at 06-12-2025 19:09
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....

BMYApril 10, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Forecast Target with 8.57% Profit: A Success Story for QuantWave  ~2 min.

BRISTOL-MYERS SQUIBB COMPANY (BMY) recently reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors....

BMYApril 10, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 8.64% Profit: QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY, a leading pharmaceutical company, recently saw its stock reach the price target forecasted by QuantWave, generating an impressive 8.64% profit for investors....



Related news

EXPEJanuary 1, 2025Expedia Group's Stock Continues to Outperform the Market Amidst Strong Recommendations  ~1 min.

Expedia Group Inc. (NASDAQ:EXPE) has been receiving positive recommendations from experts, making it an attractive option for investors....

MOSJanuary 26, 2025Heres Why You Should Add Mosaic Stock to Your Portfolio  ~1 min.

The Mosaic Company (NYSE: MOS) has been gaining attention from investors who believe the stock is currently undervalued....

AWKJanuary 25, 2025Water Utility company AWK receives "Hold" recommendation from brokerages  ~1 min.

American Water Works Company Inc. (AWK), a leading water utility company, has recently received a consensus recommendation of "Hold" from various brokerages....

ATODecember 18, 2024Atmos Energy Co. NYSE:ATO Receives Consensus Recommendation of Moderate Buy from Analysts  ~1 min.

According to reports, Atmos Energy Corporation (NYSE:ATO) has received a consensus recommendation of "Moderate Buy" from analysts....

EXPEDecember 30, 2024Expedia Group Inc. Receives Consensus Recommendation of Hold from Analysts  ~1 min.

Expedia Group Inc. (NASDAQ:EXPE) has been given a consensus recommendation of Hold by analysts....